Optiscan Imaging Stock

Optiscan Imaging EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Optiscan Imaging (OIL.AX) as of Sep 10, 2026 is -6.17 M AUD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -6.02 M AUD — a change of 2.55% (lower).

EBITDA

-6.17 MAUD

YoY

2.55%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Optiscan Imaging is 2026 -6.17 M AUD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Optiscan Imaging was 2025 -6.02 M AUD. It decreases by 2.55% lower compared to the previous year.

The Optiscan Imaging EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-1.90 M AUD
Jan 1, 2019
-2.22 M AUD
Jan 1, 2020
-1.47 M AUD
Jan 1, 2021
-2.12 M AUD
Jan 1, 2022
-3.99 M AUD
Jan 1, 2023
-3.97 M AUD
Jan 1, 2024
-6.02 M AUD
Jan 1, 2025
-6.17 M AUD
The Optiscan Imaging EBITDA history
YEAREBITDAYoY
-6.17 MAUD+2.55%
-6.02 MAUD+51.50%
-3.97 MAUD-0.50%
-3.99 MAUD+87.85%
-2.12 MAUD+44.78%
-1.47 MAUD-33.95%
-2.22 MAUD+16.69%
-1.90 MAUD-32.68%
-2.83 MAUD+113.16%
-1.33 MAUD-4.07%
-1.38 MAUD-1.19%
-1.40 MAUD—
Access this data via the Eulerpool API
Get Free API Key

Optiscan Imaging Stock analysis

What does Optiscan Imaging do? Optiscan Imaging Ltd is an Australian company specializing in the development and commercialization of advanced imaging technologies. The company was founded in 1994 and is headquartered in Notting Hill, a suburb of Melbourne. Optiscan was originally established as a spin-off company from Monash University to enable the commercial application of a groundbreaking technology called confocal microscopy. However, over the years, the company has expanded into other imaging technologies and now offers a wide range of products and services. Optiscan's business model involves developing and bringing to market innovative technologies that can be used in biomedical research and clinical diagnostics. The company works closely with research institutions and companies in various industries to develop customized imaging solutions. Optiscan offers a wide range of products, including confocal microscopes, multiphotonic microscopes, real-time imaging systems, and Raman spectrometers. These products are used in various application areas such as cancer research, neurobiology, cell biology, and materials science. Another important area for Optiscan is veterinary imaging. The company has developed a product line for veterinary medicine that is used by veterinarians and researchers around the world. Optiscan's imaging systems enable veterinarians to obtain precise and detailed images of animals to enable better diagnosis and treatment. Optiscan also operates a service department that offers customized imaging solutions to customers. The company provides services such as image processing, data analysis, and prototype development. Overall, Optiscan has become one of the leading providers of imaging technologies in Australia and globally over the past decades. The company has a long history of collaboration with leading research institutions and companies worldwide and remains committed to developing innovative solutions for the challenges of biomedicine and imaging. Optiscan Imaging is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Optiscan Imaging stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Optiscan Imaging is -6.17 M AUD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Optiscan Imaging changed from -6.02 M AUD to -6.17 M AUD, representing a 2.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Optiscan Imaging since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Optiscan Imaging historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Optiscan Imaging

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Optiscan Imaging